Effect of rebamipide, a novel antiulcer agent, on helicobacter pylori adhesion to gastric epithelial cells

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 8, 1998, Pages 1895-1899

  Hayashi, Shunji ^a   Sugiyama, Toshiro ^b   Amano, Ken Ichi ^c   Isogai, Hiroshi ^d   Isogai, Emiko ^e   Aihara, Miki ^f   Kikuchi, Mikio ^f   Asaka, Masahiro ^b   Yokota, Kenji ^g   Oguma, Keiji ^g   Fujii, Nobuhiro ^d   Hirai, Yoshikazu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c AKITA UNIVERSITY   (Japan)

^d SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^f OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^g OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

REBAMIPIDE;

ARTICLE; BACTERIUM ADHERENCE; CHRONIC GASTRITIS; CONTROLLED STUDY; DRUG EFFECT; EPITHELIUM CELL; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STOMACH CANCER; STOMACH ULCER;

EID: 0031927584     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.8.1895     Document Type: Article

References (21)

1. Evans, D. G., D. J. Evans, Jr., J. J. Moulds, and D. Y. Graham. 1988. N-Acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: a putative colonization factor antigen. Infect. Immun. 56:2896-2906.
2. Evans, D. G., T. K. Karjalainen, D. J. Evans, Jr., D. Y. Graham, and C. H. Lee. 1993. Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori. J. Bacteriol. 175:674-683.
3. Forman, D., and the Eurogast Study Group. 1993. An international association between Helicobacter pylori infection and gastric cancer. Lancet 341: 1359-1362.
4. Graham, D. Y. 1991. Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease. J. Gastroenterol. Hepatol. 6:105-113.
5. Han, B. G., H. S. Kim, K. H. Rhee, H. S. Han, and M. H. Chung. 1995. Effects of rebamipide on gastric cell damage by Helicobacter pylori-stimulated human neutrophils. Pharmacol. Res. 32:201-207.
6. Hayashi, S., T. Sugiyama, A. Yachi, K. Yokota, Y. Hirai, K. Oguma, and N. Fujii. 1997. A rapid and simple method to quantify Helicobacter pylori adhesion to human gastric MKN-28 cells. J. Gastroenterol. Hepatol. 12:373-375.
7. Ishiyama, M., M. Shiga, K. Sasamoto, M. Mizoguchi, and P. He. 1993. A new sulfonated tetrazolium salt that produces a highly water-soluble formazan dye. Chem. Pharm. Bull. 41:1118-1122.
8. Ishiyama, M., H. Tominaga, M. Shiga, K. Sasamoto, Y. Ohkura, K. Ueno, and M. Watanabe. 1995. Novel cell proliferation and cytotoxicity assays using a tetrazolium salt that produces a water-soluble formazan dye. In Vitro Toxicol. 8:187-190.
9. Lingwood, C. A., M. Huesca, and A. Kuksis. 1992. The glycerohpid receptor for Helicobacter pylori (and exoenzyme S) is phosphatidylethanolamine. Infect. Immun. 60:2470-2474.
10. Lingwood, C. A., G. Wasfy, H. Han, and M. Huesca. 1993. Receptor affinity purification of a lipid-binding adhesin from Helicobacter pylori. Infect. Immun. 61:2474-2478.
11. Motoyama, T., H. Hojo, and H. Watanabe. 1986. Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol. Jpn. 36:65-83.
12. Naito, Y., T. Yoshikawa, T. Tanigawa, K. Sakurai, K. Yamasaki, M. Uchida, and M. Kondo. 1995. Hydroxyl radical scavenging by rebamipide and related compounds: electron paramagnetic resonance study. Free Radic. Biol. Med. 18:117-123.
13. Naito, Y., T. Yoshikawa, S. Iinuma, R. Miyazaki, N. Yagi, N. Yoshida, T. Osumi, Y. Hirao, and M. Kondo. 1996. Local gastric and serum concentrations of rebamipide following oral administration to patients with chronic gastritis. Arzneimittelforschung 46:698-700.
14. Nebiki, H., T. Arakawa, K. Kioka, K. So, K. Okawa, H. Oka, H. Yamada, S. Harihara, K. Ando, T. Uchida, H. Ito, K. Higuchi, and K. Kobayashi. 1997. Increase in the rate of cure of Helicobacter pylori infection by addition of rebamipide to omeprazole plus amoxicillin. Gastroenterology 112:A232.
15. Queiroz, D. M. M., E. N. Mendes, and G. A. Rocha. 1987. Indicator medium for isolation of Campylobacter pylori. J. Clin. Microbiol. 25:2378-2379.
16. Shimizu, T., T. Akamatsu, H. Ota, and T. Katsuyama. 1996. Immunohistochemical detection of Helicobacter pylori in the surface mucous gel layer and its clinicopathological significance. Helicobacter 1:197-206.
17. Smoot, D. T., J. H. Resau, M. H. Earlington, M. Simpson, and T. L. Cover. 1996. Effects of Helicobacter pylori vacuolating cytotoxin on primary cultures of human gastric epithelial cells. Gut 39:795-799.
18. Suzuki, M., S. Miura, M. Mori, A. Kai, H. Suzuki, D. Fukumura, M. Suematsu, and M. Tsuchiya. 1994. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants. Gut 35:1375-1378.
19. Uchida, M., F. Tabusa, M. Komatsu, S. Morita, T. Kanbe, and K. Nakagawa. 1985. Studies on 2(1H)-quinolinone derivatives as gastric antiulcer active agents. 2-(4-Chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl]propionic acid and related compounds. Chem. Pharm. Bull. 33:3775-3786.
20. Warren, J. R., and B. J. Marshall. 1983. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet i:1273-1275.
21. Wyatt, J. I., and M. F. Dixon. 1988. Chronic gastritis - a pathogenic approach. J. Pathol. 154:113-124.